[1]
Kaur, P. et al. 2017. Analysis of Non-Pivotal Bioequivalence Studies Submitted in Abbreviated New Drug Submissions for Delayed-Release Drug Products. Journal of Pharmacy & Pharmaceutical Sciences. 20, (Jul. 2017), 252–257. DOI:https://doi.org/10.18433/J39S6Z.